US FDA approves Precigen's immunotherapy for rare respiratory disease

U

US FDA approves Precigen's immunotherapy for rare respiratory disease  The U.S. Food and Drug Administration has approved Precigen's (PGEN.O), opens new tab immunotherapy to treat adults with...